ProPublica

Journalism in the Public Interest

Cancel
Health Care

Discussion: Why Medicare Wastes Billions on Name-Brand Drugs

Yesterday, we published an investigation into how Medicare's popular drug program has failed to rein in medical providers who heavily prescribe pricey, name-brand drugs, instead of cheaper generics. Part D has wasted billions in its eight-year history – even though other federal agencies, and some private health plans, have regulations in place that encourage the use of generics and cut costs. 

In contrast, Medicare’s low-income subsidy encourages name-brand prescribing by keeping co-pays so low that there's little incentive to use generics. President Obama has proposed a fix in his budget, but Congress has declined to take it up. 

The VA and the military, as well as insurers like Kaiser Permanente, have had success encouraging the use of generic drugs. So why hasn't Medicare tried similar tactics? What kinds of limits could the agency place on doctors' prescribing, and why hasn't it yet? Do name-brand drugs really have an advantage over generics? 

Join reporters Charles Ornstein and Tracy Weber today at 1 PM E.T. to ask your questions in a live discussion, in partnership with Digital First Media. The chat will happen at this URL. Please feel free to leave your questions in advance. If you can't make it, there will be a transcript of the chat on this page afterwards

blog comments powered by Disqus

Projects You Can Help With

.

Meet Our New Comments System – Where You Can Share Your Stories, Too

Learn More

.

Weigh In: Do HIV Laws Protect or Persecute?

Join the discussion

Responses

.

What’s Your Obamacare Story? Help ProPublica Cover the Affordable Care Act

Share

237 Stories Shared

.

Discussion: Acetaminophen Risks, Safety Measures

Ask A Question

More on This Investigation

Even After Doctors Are Sanctioned or Arrested, Medicare Keeps Paying

A ProPublica analysis of recently released data shows that dozens of physicians who received payments from Medicare in 2012 had been kicked out of Medicaid, charged with fraud, or settled claims of overbilling Medicare itself.

The Perils of Problematic Prescribing: A Double Dose of Warnings

Two new reports from the CDC show the dangers of overprescribing narcotics and antibiotics. Is there a way for doctors and consumers to make better decisions?

Medicare’s Drug Program Needs Stronger Protections Against Fraud, Watchdog Says

A new report finds that more than half of insurance companies in Medicare’s drug program haven’t reported fraud cases to the government. The findings echo an earlier ProPublica investigation that found fraud flourishing in the program.

Some Predictions on How Medicare Will Release Physician Payment Data

Medicare will soon begin to release data about how much it pays doctors. The details are still unknown, but three recent projects offer some clues.